BIOGEN INC. - 8-K Filing

Biogen reports Q2 revenue of $2.7B, up 3% YoY, driven by strong growth portfolio and new product launches (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $BIIB

Read the full article at SEC EDGAR

More Regulatory news